Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis

Ioannis Kyriakoulis(University of Thessaly), George Ntaios(University of Thessaly), Anastasia Adamou(University of Thessaly), David‐Dimitris Chlorogiannis(General University Hospital of Patras), Ioannis Kardoutsos(University of Thessaly), Despoina Koukousaki(University of Minnesota), Iliana Stamatiou(University Hospital of Alexandroupolis)

European Journal of Internal Medicine

August 28, 2023

10.1016/j.ejim.2023.08.020

Cited by 27

Related Papers

Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke

|European Heart Journal|2022|138

Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention

|Stroke|2019|95

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?

|EP Europace|2018|94

Albumin Levels and Risk of Early Cardiovascular Complications After Ischemic Stroke: A Propensity-Matched Analysis of a Global Federated Health Network

|Stroke|2024|41

Temporal trends in organ donation among cardiac arrest patients treated with extracorporeal cardiopulmonary resuscitation

|Resuscitation|2024|16